European Healthtech startup funding raised during H1 2020.
In H1 2020, 200 European Healthtech companies raised a combined €2.4B across 203 funding rounds, up 15.0% versus H1 2019. UK led by capital raised, and High-Tech Grunderfonds was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CureVac | Early VC | Jun 2020 | €300M |
| Oxford Nanopore Technologies | Other | Apr 2020 | €124M |
| Compass Pathways | Series B | Apr 2020 | €74M |
| Compugen | Other |
28 exits · €1.2B disclosed.
| Polyplus-Transfection | Acquisition | Feb 2020 | €460M |
| Galecto | Acquisition | Jan 2020 | €398M |
| MaSTherCell | Acquisition | Feb 2020 | €285M |
| Inui Health | Acquisition | Jun 2020 | €8.0M |
| 2CSI | Acquisition | Apr 2020 | €2.1M |
| ApiFix | Acquisition | Apr 2020 | €1.8M |
| Mar 2020 |
| €68M |
| Cera | Other | Feb 2020 | €65M |
| Verve Therapeutics | Series A | Jun 2020 | €56M |
| Exscientia | Series C | May 2020 | €55M |
| Oxford Nanopore Technologies | Other | May 2020 | €54M |
| Avacta Group | Growth/Late | Apr 2020 | €51M |
| Dynacure | Series C | Feb 2020 | €50M |
| Enterome | Series D+ | Jun 2020 | €46M |
| Doktor.se | Series C | May 2020 | €45M |
| K Health | Series C | Feb 2020 | €44M |
| Robocath | Series C | Apr 2020 | €40M |
| Northsea Therapeutics | Series B | Jan 2020 | €36M |
